ArticleLife sciences2012

The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.

Minxian Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.